Trevi Therapeutics, Inc. <TRVI.O>: H.C. Wainwright Raises Target Price to $24 From $21
TRVI•Related News
Houthi Red Sea blockade would lift oil prices, but workarounds could limit impact
XLE•
Asian stocks rise as Mideast mediation takes oil lower
SPY•
MasTec - Borrows $700 Million Under New Term Loan Agreement On July 20, 2026 - SEC Filing
MTZ•
Fulcrum Therapeutics 10% owner Kevin Tang acquires $594,132 of common shares
FULC•
Ecopetrol’s Brava Energia takeover bid sets Aug. 5 auction date, drops CADE and debenture waiver conditions
EC•